Corrigendum: Activation of A2A receptor by PDRN reduces neuronal damage and stimulates WNT/β-catenin driven neurogenesis in spinal cord injury(Front. Pharmacol., (2018), 9, (506), 10.3389/fphar.2018.00506)

Abstract

In the published article, the Conflict of interest statement was incorrect. The correct Conflict of interest statement appears below: Conflict of interest “The author FS has received research support from Mastelli for work on polydeoxyribonucleotide. Authors FS, AB and DA are co-inventors on a patent describing therapeutic polydeoxyribonucleotide activity in chronic intestinal disease. Author LM, FS and AB are co-inventor on a patent describing therapeutic polydeoxyribonucleotide activity in testicular injury by torsion. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest”. The authors apologize for this error and state that this does not change the scientific conclusion of the article in any way. The original article has been updated.